AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H2035-H2042, 2006. First published December 22, 2005; doi:10.1152/ajpheart.00772.2004
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/H2035    most recent
00772.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonscherowski, V.
Right arrow Articles by Zahler, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonscherowski, V.
Right arrow Articles by Zahler, S.

Calpains: a physiological regulator of the endothelial barrier?

Vera Gonscherowski,1 Bernhard F. Becker,1 Louis Moroder,2 Elena Motrescu,3 Shirley Gil-Parrado,4 Torsten Gloe,1 Matthias Keller,1 and Stefan Zahler1

1Department of Physiology, University of Munich, Munich; 2Max-Planck Institute for Biochemistry, Martinsried; 3Technical University of Munich, Munich; and 4Department of Clinical Chemistry and Clinical Biochemistry, University of Munich, Munich, Germany

Submitted 30 July 2004 ; accepted in final form 14 December 2005

The intracellular protease calpain, abundant in endothelial cells (EC), is assumed to be inactive under physiological conditions but may account for Ca2+-linked pathophysiological events. However, nonstimulated EC contained autolyzed, activated calpain. Adding 12–48 µM calpain inhibitor I (CI) or 0.5–1 µM of the novel, membrane-permeable conjugate of calpastatin peptide-penetratin (CPP) caused rapid rounding and retraction of cultured EC (phase contrast, capacitance) and translocation of Syk, Rac, and Rho to the membrane, signifying activation upon inhibition of calpain. Isolated hearts (guinea pig) perfused with 12 µM CI or 0.5 µM CPP developed coronary leak. We conclude that calpain is constitutively active in EC and regulates vascular permeability by governing cell-cell attachment.

cell retraction; calpastatin; endothelium; coronary permeability; reperfusion



Address for reprint requests and other correspondence: B. F. Becker, Dept. of Physiology, Univ. of Munich, Schillerstr. 44, 80336 Munich, Germany (e-mail: b.f.becker{at}lrz.uni-muenchen.de)




This article has been cited by other articles:


Home page
DiabetesHome page
R. Scalia, Y. Gong, B. Berzins, L. J. Zhao, and K. Sharma
Hyperglycemia Is a Major Determinant of Albumin Permeability in Diabetic Microcirculation: The Role of {micro}-Calpain
Diabetes, July 1, 2007; 56(7): 1842 - 1849.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.